The global Pancreatic And Biliary Stents Market was valued at USD 354.2 million in 2023 and is projected to reach USD 511.47 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% over the forecast period of 2024-2031. This growth is driven by the increasing prevalence of pancreatic and biliary diseases, advancements in stent technology, and the growing number of minimally invasive procedures globally.
Get Free Sample Report on Pancreatic and Biliary Stents Market
https://www.snsinsider.com/sample-request/1201
Pancreatic and biliary stents are medical devices that are used to treat various conditions of the pancreas and bile ducts, including chronic pancreatitis, bile duct obstruction, pancreatic cancer, and gallstones. These stents are inserted into the ducts to help maintain their patency, ensuring the normal flow of bile or pancreatic fluids. The increasing incidence of gastrointestinal disorders, such as pancreatitis and bile duct blockages, has significantly contributed to the demand for these devices.
Key Drivers of Market Growth
- Increasing Prevalence of Pancreatic and Biliary Disorders: The global rise in pancreatic and biliary diseases, including conditions such as pancreatitis, cholangiocarcinoma (bile duct cancer), and pancreatic cancer, is one of the primary factors contributing to the growth of the pancreatic and biliary stents market. According to the World Health Organization (WHO), pancreatic cancer is one of the leading causes of cancer-related deaths worldwide. As these diseases continue to affect an increasing number of people, the demand for stents, particularly in the management of these conditions, is expected to rise significantly.
- Rising Adoption of Minimally Invasive Procedures: Minimally invasive procedures, including the use of endoscopic techniques to insert pancreatic and biliary stents, are increasingly preferred due to their lower risks, shorter recovery times, and reduced discomfort for patients. The growing trend of performing complex gastrointestinal procedures with minimal incision and reduced risk of complications is driving the demand for pancreatic and biliary stents. These procedures help to address conditions such as obstructed bile ducts, improving patients' quality of life and reducing the need for traditional surgery.
- Technological Advancements in Stent Designs: The development of advanced stent technologies, including drug-eluting stents (DES) and biodegradable stents, is another key factor contributing to the market's growth. Drug-eluting stents, which release medication over time to prevent stent occlusion and restenosis, are increasingly being used to improve treatment outcomes. Biodegradable stents, which dissolve naturally over time, are expected to gain popularity due to their ability to reduce the need for removal procedures. These advancements are expected to boost the effectiveness of treatments and improve patient outcomes, further driving the growth of the pancreatic and biliary stents market.
- Growing Demand for Advanced Medical Treatments: As healthcare systems across the globe continue to improve, the demand for advanced medical treatments is on the rise. This includes the increased use of stents for the management of complex pancreatic and biliary conditions. Rising healthcare expenditures and the increasing availability of healthcare services in emerging economies are expected to drive the adoption of pancreatic and biliary stents in these regions, further expanding the market.
- Aging Population: The aging global population is another important driver for the growth of the pancreatic and biliary stents market. Older individuals are more susceptible to pancreatic and biliary diseases due to factors such as weakened immune systems, chronic conditions, and lifestyle factors. As the population of elderly individuals continues to rise, the demand for medical devices like pancreatic and biliary stents to manage these conditions is expected to increase.
- Improved Diagnosis and Awareness: As awareness of pancreatic and biliary diseases grows, more people are seeking medical attention and receiving early diagnoses. Improvements in diagnostic imaging and technologies, such as endoscopic retrograde cholangiopancreatography (ERCP), have enabled better detection of blockages, stenosis, and other conditions affecting the bile ducts and pancreas. This early detection allows for timely intervention and the increased use of stents to treat these conditions.
KEY MARKET SEGMENTATION
By Product Type
- Metal Stents
- Plastic Stents
By Applications
- Bilio-pancreatic leakages
- Pancreatic Cancer
- Benign Biliary strictures
- Others
By End Users
- Hospitals
- Ambulatory Surgical Centers
- Speciality Clinics
- Others
Make Enquiry about Pancreatic and Biliary Stents Market
https://www.snsinsider.com/enquiry/1201
Competitive Landscape
The pancreatic and biliary stents market is competitive, with several key players leading the industry. Prominent companies include Boston Scientific Corporation, Cook Medical, Medtronic, Abbott Laboratories, and Terumo Corporation. These companies are focused on product innovation, expanding their market presence, and forming strategic partnerships to maintain a competitive edge.
- Boston Scientific Corporation: Boston Scientific offers a range of advanced pancreatic and biliary stents, including self-expanding metal stents and plastic stents, and is a leader in the market due to its continuous innovation and product development.
- Cook Medical: Cook Medical is another major player in the pancreatic and biliary stents market, known for its high-quality stent offerings and its commitment to advancing minimally invasive treatments.
- Medtronic: Medtronic is a leading global healthcare company that provides a wide range of stents for various applications, including pancreatic and biliary treatments. The company's strong presence in the global medical device market gives it a competitive edge.
Conclusion
The pancreatic and biliary stents market is expected to experience significant growth, driven by the increasing prevalence of pancreatic and biliary diseases, the growing demand for minimally invasive treatments, and advancements in stent technology. With a projected market value of USD 511.47 million by 2031, the market is set to benefit from innovations such as biodegradable stents, drug-eluting stents, and improvements in stent design. As the demand for advanced gastrointestinal treatments continues to rise, pancreatic and biliary stents will play a critical role in managing these complex conditions, improving patient outcomes, and contributing to the overall growth of the healthcare industry.
About US:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)